This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignees: Glac Biotech Co., Ltd., Glac Biotech Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Ko-Chiang Hsia: Innovator in Lactic Acid Bacterial Applications
Introduction
Ko-Chiang Hsia, an accomplished inventor based in Tainan, Taiwan, has made significant contributions to the field of biotechnology. With a total of two patents to his name, Hsia focuses on innovative methods utilizing lactic acid bacteria to address health issues.
Latest Patents
Hsia's latest patents include a method for alleviating atopic dermatitis and a lactic acid bacterial composition for treating or preventing jaundice. The first patent discloses a method employing a composition that contains at least one strain of lactic acid bacteria, specifically AP-32 and CP-9, which are deposited at the China Center for Type Culture Collection (CCTCC) under designated accession numbers. This invention aims to provide effective relief for individuals suffering from atopic dermatitis.
The second patent centers around a composition intended to inhibit the activity of jaundice. It involves administering a lactic acid bacterial composition containing the AP-32 and CP-9 strains to individuals in need. This innovative approach aims to offer a preventative measure as well as a treatment for jaundice.
Career Highlights
Ko-Chiang Hsia is affiliated with Glac Biotech Co., Ltd., a company dedicated to advancing biotechnological applications. His work at Glac Biotech positions him at the forefront of research and innovation in this rapidly evolving field.
Collaborations
Throughout his career, Hsia has collaborated with esteemed colleagues such as Hsieh-Hsun Ho and Yi-Wei Kuo. These partnerships emphasize the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results within the industry.
Conclusion
Ko-Chiang Hsia’s innovative contributions in the realm of biotechnology, particularly utilizing lactic acid bacteria for health applications, underscore the potential for alternative methods in treating various conditions. His patents not only reflect his dedication to research but also highlight the ongoing advancements in microbiology and its applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile